NDC 63323-751-00 - Phenylephrine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-751
- Requested NDC
- 63323-751-00
- Package NDCs from labels
- 63323-751-05, 63323-751-10, 63323-751-00, 63323-751-01, 63323-751-03, 63323-751-13
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2026-10-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Phenylephrine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2026-10-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Phenylephrine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-05-15 | HUMAN PRESCRIPTION DRUG LABEL |
| PHENYLEPHRINE HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Phenylephrine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-751-00 | Phenylephrine Hydrochloride | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | 8 | |
| 63323-751-01 | Phenylephrine Hydrochloride | 25 in 1 CARTON | INJECTION | 25 | 8 | |
| 63323-751-05 | Phenylephrine Hydrochloride | 5 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION | 5 | 4 | |
| 63323-751-05 | Phenylephrine Hydrochloride | 1 in 1 CARTON | INJECTION | 1 | 4 | |
| 63323-751-10 | Phenylephrine Hydrochloride | 10 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION | 10 | 4 | |
| 63323-751-10 | Phenylephrine Hydrochloride | 1 in 1 CARTON | INJECTION | 1 | 4 | |
| 63323-751-03 | Phenylephrine Hydrochloride | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | 2 | |
| 63323-751-13 | Phenylephrine Hydrochloride | 25 in 1 CARTON | INJECTION | 25 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-751 | PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE) INJECTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 2 package rows | 20231208_1e77b9c8-fa17-4aa4-adc8-ff716ab2e5d7.zip |
| 63323-751 | PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE) INJECTION [FRESENIUS KABI USA, LLC ] | 4 | Current NDC, Legacy NDC, 4 package rows | 20240125_c7026b15-1228-4acb-beed-4474fcdbb972.zip |
| 63323-751 | PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE) INJECTION [FRESENIUS KABI USA, LLC ] | 2 | Current NDC, Legacy NDC, 2 package rows | 20240110_f2dce7f1-6538-4747-9792-665eee45c0a9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-751-00 | ML - Milliliter | 63323-751 | 1394c34e-4c42-4094-b1b2-afcdc13e132b | 1 | 2019-07-02 |
| 63323-751-01 | ML - Milliliter | 63323-751 | a8b40ddc-6423-477a-9e40-f4a05b934ade | 1 | 2019-07-02 |
| 63323-751-03 | ML - Milliliter | 63323-751 | cf951bf5-4a25-4cb0-9c6b-c9e4c8cb2180 | 1 | 2020-08-06 |
| 63323-751-05 | ML - Milliliter | 63323-751 | 321cea9d-af97-405d-9cb3-812f3c5e23d3 | 1 | 2019-07-02 |
| 63323-751-10 | ML - Milliliter | 63323-751 | 9610d875-e8cc-4c7b-83b7-8b4ebf6a4e9e | 1 | 2019-07-02 |
| 63323-751-13 | ML - Milliliter | 63323-751 | ec8453b5-99f8-4776-90d2-3d17719905cf | 1 | 2020-08-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cold Medicine XL3 FORTE | ACETAMINOPHEN CHLORPHENIRAMINE MALEATE PHENYLEPHERINE HYDROCHLORIDE | Selder, S.A. de C.V. | 51dd467b-aae8-41fa-e054-00144ff8d46c | 2024-10-24 | Warnings | 04JA59TNSJ |
| Cold Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | PUBLIX SUPER MARKETS INC | 68a5930b-37db-439d-8fb9-7d7de07d8465 | 2024-10-24 | Warnings | 04JA59TNSJ |
| sinus pressure pain and cough | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | PUBLIX SUPER MARKETS INC | bb0225d5-6c32-2c64-e053-2995a90a829b | 2024-10-24 | Warnings | 04JA59TNSJ |
| Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | PUBLIX SUPER MARKETS INC | 01e1ad15-0ef5-4d6a-a9c1-19a5f2b20148 | 2024-10-24 | Warnings | 04JA59TNSJ |
| Complexion HP | CARBO ANIMALIS, CARBO VEGETABILIS, KALI BICHROMICUM, KALI IODATUM, NATRUM MURIATICUM, PULSATILLA (PRATENSIS), SEPIA, SILICEA, SULPHUR, ZINCUM METALLICUM | Energique, Inc. | ad12d51e-04cb-4833-b802-0038796966ff | 2024-10-24 | Warnings | 451W47IQ8X |
| CareOne Fast Acting Nasal | PHENYLEPHRINE HYDROCHLORIDE | American Sales Company | 95b22dce-ef54-4ab5-9cc3-0e1cefa09ec5 | 2024-10-24 | Warnings | 04JA59TNSJ |
| DAYTIME COLD AND FLU MULTI-SYMPTOM RELIEF | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | Chain Drug Consortium, LLC | 8cb0d0c8-c565-4c5a-97c5-8250a67e23a8 | 2024-10-24 | Warnings | 04JA59TNSJ |
| CV HP | ADONIS VERNALIS, LACHESIS MUTUS, LYCOPUS VIRGINICUS, VALERIANA OFFICINALIS, AURUM METALLICUM, CACTUS GRANDIFLORUS, DIGITALIS PURPUREA, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), | ENERGIQUE, INC. | c06763c5-8bde-4251-bd41-67becf8ce8c4 | 2024-10-24 | Warnings | 451W47IQ8X |
| Femstat C | ECHINACEA (ANGUSTIFOLIA), FUCUS VESICULOSUS, HYDRASTIS CANADENSIS, PHYTOLACCA DECANDRA, KREOSOTUM, NATRUM MURIATICUM, CANDIDA ALBICANS, LYCOPODIUM CLAVATUM, PULSATILLA (PRATENSIS), SEPIA | Energique, Inc. | 2af0dc7b-5f8b-44fa-9589-bc95043428e9 | 2024-10-24 | Warnings | 451W47IQ8X |
| rexall hemorrhoidal | COCOA BUTTER, PHENYLEPHRINE HCL | Dolgencorp Inc | 0415c51b-5a12-49d4-8968-0131ddb85545 | 2024-10-23 | Warnings | 04JA59TNSJ |
| Exchange Select Hemorrhoidal | COCOA BUTTER, PHENYLEPHRINE HCL | Army & Air Force Exchange Service | 8155ed74-9412-498f-998c-4a29c46e934f | 2024-10-23 | Warnings | 04JA59TNSJ |
| Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | MARC GLASSMAN, INC. | e2325f33-e4e4-1269-e053-2995a90ab4ac | 2024-10-23 | Warnings | 04JA59TNSJ |
| Sinus Pressure plus Pain PE | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | MARC GLASSMAN, INC. | a8240d98-f0b0-3ded-e053-2a95a90a5cf9 | 2024-10-23 | Warnings | 04JA59TNSJ |
| Sinus plus Headache | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | MARC GLASSMAN, INC. | a82401f5-65b1-11e9-e053-2a95a90a499e | 2024-10-23 | Warnings | 04JA59TNSJ |
| Allergy Multi Symptom | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HYDROCHLORIDE | MARC GLASSMAN, INC. | a823db21-4863-45a6-e053-2995a90ab8e6 | 2024-10-23 | Warnings | 04JA59TNSJ |
| Cold Max | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | MARC GLASSMAN, INC. | e2346d0c-75cf-974c-e053-2a95a90a2857 | 2024-10-23 | Warnings | 04JA59TNSJ |
| Cold Multi-Symptom Nighttime | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Marc Glassman, Inc. | ce573785-f77d-4314-9b7a-ef3f1f4f34d8 | 2024-10-23 | Warnings | 04JA59TNSJ |
| Cold plus Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | MARC GLASSMAN, INC. | e41a3dcc-45b4-4093-e053-2995a90a3b14 | 2024-10-23 | Warnings | 04JA59TNSJ |
| Cold plus Head Congestion Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | MARC GLASSMAN, INC. | e41a7cc5-bd0e-b92b-e053-2995a90af50a | 2024-10-23 | Warnings | 04JA59TNSJ |
| Leader Hemorrhoidal | COCOA BUTTER, PHENYLEPHRINE HCL | Cardinal Health 110, LLC. dba Leader | c4814524-0f4c-4351-a431-5b4b6431fd28 | 2024-10-23 | Warnings | 04JA59TNSJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.